Table 4.
Calculations for evaluation of APRI as a sole marker of fibrosis in the entire cohort
| APRI≥0.308 | APRI≤0.308 | Total | |
| Fibroscan ≥6 kPa | 9 (12%) | 9 (12%) | 18 (24%) |
| Fibroscan <6 kPa | 13 (18%) | 43 (58%) | 56 (76%) |
| Total | 22 (30%) | 52 (70%) | 74 (100%) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.